Prevalence and factors associated with flares following COVID-19 mRNA vaccination in patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: a national cohort study.

Weng Seng Warren FongTing Hui WoonLi-Ching ChewAndrea LowAnnie LawYih Jia PohSiaw Ing YeoYing Ying LeungMargaret MaAmelia SantosaKok Ooi KongChuanhui XuGim Gee TengAnselm MakSen Hee TayTyng Yu ChuahNur Emillia RoslanStanley AngkodjojoKee Fong PhangMelonie SriranganathanTeck Choon TanPeter CheungManjari Lahiri

Published in: Advances in rheumatology (London, England) (2023)

About one-fifth of patients experienced a disease flare post COVID-19 mRNA vaccination, but most flares were non-severe. Patients with active disease prior to vaccination should be monitored closely for disease flares, especially in patients with RA.

Keyphrases

coronavirus disease
sars cov
end stage renal disease
ejection fraction
chronic kidney disease
ankylosing spondylitis
peritoneal dialysis
early onset
patient reported outcomes
systemic lupus erythematosus
systemic sclerosis